Salas, Elvie V.
HRN: 25-31-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2024
CEFUROXIME 1.5GM (VIAL)
06/29/2024
06/29/2024
IV
1.5gm
LD
Elective D And C
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes